-
-
-
-
-
-
-
Wolfe Research Upgrades Abbvie (ABBV) to Outperform
-
-
-
-
-
-
-
AbbVie Q2 earnings preview: analysts eye immunology growth, pipeline
-
-
-
-
-
-
-
AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion
-
-
-
-
-
-
-
AbbVie to Host First-Quarter 2026 Earnings Conference Call
-
-
-
-
-
-
-
This U.S. biotech stock is Bernstein's Top Pick for 2026
-
-
-
-
-
-
-
HSBC Upgrades Abbvie (ABBV) to Buy
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $242 at Guggenheim, 'Looking for Additional Treats on Halloween to Drive Further Upside'
-
1,233,818 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


